The FDA has approved the first conjugate vaccine that protects against 20 Streptococcus pneumoniae serotypes in adults aged 18 years and older.
The accelerated approval pathway is used when a medication is found to provide a significant advantage over other approved treatments for serious or life-threatening conditions.
The US Food and Drug Administration has approved a drug for chronic weight management in adults with overweight or obesity and at least one weight-related condition.
The First Once-Daily Treatment for Heavy Menstrual Bleeding Related to Uterine Fibroids Is Now Approved
The approval comes after positive results from the LIBERTY 1 and 2 studies were published, which showed safety and efficacy of the medication after 24 weeks.
The US Food and Drug Administration has authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents aged 12 through 15 years.
The US Food and Drug Administration have announced their approval of a higher dose of naloxone hydrochloride nasal spray for the treatment of opioid overdose.
The US Food and Drug Administration has approved a new nonstimulant drug for the treatment for attention-deficit/hyperactivity disorder in children.
The US Food and Drug Administration cleared a test that detects Chlamydia trachomatis and Neisseria gonorrhoeae in roughly 30 minutes, for use in point-of-care settings.
The FDA has approved a new treatment option for adults with relapsing multiple sclerosis (MS).
On February 27, 2021, the US Food and Drug Administration issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine. This is the third vaccine authorized by the FDA to prevent COVID-19.